NBP today
$0.83-$0.03 (-3.60%)close Nov 12, 2026Trend
DailyDowntrend (starting)
4 hourStrong Bearish
1 hourStrong Bearish
15 minStrong Bearish
5 minStrong Bearish
Daily trend turns up above $2.27
Key levels
Resistance$0.93
Resistance$0.84
Support$0.69
Support$0.59
Latest news & SEC filings
NewsNovaBridge Biosciences picks Chuck Silberstein to lead finance
ProductNovaBridge Biosciences Presents Phase 1b Results for Givastomig at ESMO 2026
All NBP news →About NovaBridge Biosciences
NovaBridge Biosciences is a biotechnology platform company that creates separate subsidiaries to develop promising medical treatments, working with partners to identify and advance these programs. Its securities trade on the Nasdaq Global Market. The company is incorporated in the Cayman Islands and operates mainly outside that jurisdiction.
Based on the company's 20-F filed Apr 7, 2026.
Nasdaq · Healthcare
NovaBridge Biosciences (NBP)
What Is the Price Target for NBP?
SEPT Low Target
$9.00
SEPT Mid Target
$9.00
SEPT High Target
$9.00
Analyst Consensus
$9.00
Is NBP a Buy or Sell Right Now?
Thesis
- •Revenue growing -71.4% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for NBP.
Start Free Trial →Is NBP Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$9.00
25
Moat Score
NONE
1/9
Piotroski Score
-2.7
Altman Z-Score
What Is Smart Money Doing with NBP?
Insider Signal
SELLING
1 buys / 5 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Dennis Phillip Andrew | officer | Sale | 8,209 | $6K | Sep 18, 2026 |
| Dennis Phillip Andrew | officer | Buy | 23,695 | - | Sep 17, 2026 |
| Cao Sean Wuxiong | officer | Sale | 107,978 | $80K | Sep 9, 2026 |
| Cao Sean Wuxiong | officer | Buy | 235,136 | - | Sep 3, 2026 |
| Cao Sean Wuxiong | officer | Buy | 104,236 | - | Sep 3, 2026 |
| Xu Cong Claire | officer | Sale | 3,282 | $3K | Aug 31, 2026 |
| Xu Cong Claire | officer | Buy | 9,382 | - | Aug 30, 2026 |
| Xu Cong Claire | officer | Sale | 3,494 | $14K | Jun 1, 2026 |
| Cao Sean Wuxiong | director officer | Sale | 21,399 | $43K | May 14, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →NBP Growth Story
Revenue YoY
-71.4%
3yr Revenue CAGR
-3.5%
EPS Growth YoY
-75%
FCF Growth YoY
60.9%
Revenue Trend
STRONG
Dark Pool Trades for NBP
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for NBP, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:59:56 | $0.86 | 1,000 | $$865 | BUY |
| 20:50:16 | $0.88 | 6,224 | $$6K | BUY |
| 20:50:03 | $0.87 | 3,800 | $$3K | SELL |
| 20:46:03 | $0.87 | 1,000 | $$873 | SELL |
| 20:46:03 | $0.87 | 2,100 | $$2K | SELL |
5 dark pool trades shown · $$12K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for NovaBridge Biosciences (NBP) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →NBP — frequently asked questions
What is NBP stock price today?
NovaBridge Biosciences (NBP) is at $0.83, down 3.60% (-$0.03) at the Nov 12, 2026 close.
Why is NBP stock moving today?
Latest NBP news — Oct 28, 2026: NovaBridge Biosciences picks Chuck Silberstein to lead finance · Oct 26, 2026: NovaBridge Biosciences Presents Phase 1b Results for Givastomig at ESMO 2026
What is the NBP price target?
The average analyst price target for NBP is $9.00, ranging from $9 to $9, based on 1 analysts.
What do analysts rate NBP?
Analyst ratings for NBP: 0 Buy, 2 Hold, 0 Sell — consensus Hold.
Did NBP beat earnings?
NBP last reported on Aug 19, 2026: EPS -$0.02 vs -$0.03 expected — a beat of 20.0%.
Does NBP pay a dividend?
NBP does not currently pay a dividend.
What are NBP support and resistance levels?
Support: $0.69, $0.59. Resistance: $0.84, $0.93, $1.01.
What are insiders doing with NBP?
Insider activity: SELLING, 1 buys and 5 sells in the last 90 days.
What is the latest news on NBP?
Oct 28, 2026: NovaBridge Biosciences picks Chuck Silberstein to lead finance · Oct 26, 2026: NovaBridge Biosciences Presents Phase 1b Results for Givastomig at ESMO 2026